Stocks in Action USA: IDEAYA Biosciences, Leggett & Platt, Revolution Medicines

IDEAYA Biosciences (IDYA) – Oncology specialist achieves clinical breakthrough: Stock explosion after convincing study data in eye cancer therapy! The stock of IDEAYA Biosciences is massively in focus for investors as the week starts, after the company impressed with positive study data for its cancer medication. In a late-stage Phase 2/3 clinical trial, the combination therapy of Darovasertib and Xalkori , developed by Pfizer , significantly achieved its primary endpoint. According to the company, the progression-free survival (PFS) extends...